Incidence and Attributing Factors of Impaired Blood Glucose in Non-Diabetic Patients on Steroid Therapy

Authors

  • Hafsa Farooq Senior Registrar, Department of Medicine, Sheikh Zayed Hospital Lahore
  • Muhammad Awais Abid Assistant Professor Department of Medicine, Services Hospital Lahore
  • Hamna Farooq Senior Registrar Department of Medicine, Services Hospital Lahore
  • Madiha Fazil Senior Registrar Department of Medicine, Services Hospital Lahore
  • Ayesha Irshad Assistant Professor Department of Medicine, Services Hospital Lahore
  • Ambreen Butt Associate Professor Department of Medicine, Services Hospital Lahore

DOI:

https://doi.org/10.48036/apims.v17i3.383

Keywords:

hyperglycemia, Steroids

Abstract

Objective: To determine the incidence and attributing factors of impaired blood glucose in non-diabetic patients on steroid therapy.

Methodology: This descriptive study was conducted at the Department of Medicine, Sheikh Zayed Hospital Lahore during 6 months from April 2019 to September 2019. Patients of both genders with age of 18-70 years and receiving steroid therapy (at least 1 pulse) were included. After taking ethical approval, 371 patients were counseled and explained the details of the study. A bolus of 1 gram Methylprednisolone was given and blood was drawn after 2 hours and blood glucose levels were measured. All the labs were acquired from same lab (Hospital lab) and glucometer to eliminate bias and confounding variables were controlled by exclusion. Data was collected via study proforma.

Results: The average age of the patients was 43.75 ± 14.33 years with a range of 18 to 70 years. There were 42% males and 57%.1 females with a male to female ratio of 1:1.3. Average BMI of patients 27.34±3.72kg/m2. Impaired blood glucose was observed in 55% of patients after steroid pulse therapy. Frequency of impaired blood glucose after steroid pulse therapy was statistically insignificant according to age and BMI (p->0.05). Positive family history was significantly higher in a patient with impaired blood glucose after pulse therapy (p-0.001).

Conclusion: Impaired blood glucose level was observed to be highly prevalent among non-diabetic patients receiving steroid pulse therapy. Female gender and positive family history of diabetes observed as attributing factors.

Published

2021-11-15

Issue

Section

Original Articles